Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible infections Age: Adult Condition: Mild infection |
Dose: Deep Intramuscular or Slow Intravenous – 0.25-0.5 g Frequency: every 8 hours Note: Slow intravenous injection to be given over 3-5 minutes, or via intermittent or continuous intravenous infusion. |
|
Indication: Susceptible infections Age: Adult Condition: Moderate to severe infection |
Dose: Deep Intramuscular or Slow Intravenous – 0.5-1 g Frequency: every 6-8 hours Note: Slow intravenous injection to be given over 3-5 minutes, or via intermittent or continuous intravenous infusion. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible infections Age: Child: greater than 1 year |
Dose: Injection – 25-50 mg/kg daily Frequency: in 3 or 4 divided doses Note: to be given by deep intramuscular injection, slow intravenous injection over 3-5 minutes, or intermittent or continuous intravenous infusion. Maximum: 100 mg/kg daily in divided doses for severe infections. |
|
Indication: Infections With Gram-Positive Cocci Age: Neonates (less than 28 days) Condition: less than 7 days |
Dose: Intravenous/Intramuscular – 40 mg/kg/day Frequency: divided every 12 hours |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment with Creatinine Clearance less than 10 ml/min |
Dose: Dosage – Half the usual dose Frequency: every 18-24 hours |
|
Condition: Renal impairment with Creatinine Clearance 11-34 ml/min |
Dose: Dosage – Half the usual dose Frequency: every 12 hours |
Administration
- Given as IV or IM injection
- Must be administered by healthcare professionals
Side Effect
- Diarrhoea
- oral candidiasis
- vomiting
- nausea
- stomach cramps
- anorexia
- eosinophilia
- itching
- drug fever
- skin rash
- Stevens-Johnson syndrome
- neutropenia
- leucopenia
- thrombocytopenia
- thrombocythemia
- transient elevation in SGOT
- SGPT and alkaline phosphatase levels
- hepatitis
- increased BUN and creatinine levels
- renal failure
- phlebitis
- induration
- genital and anal pruritus (eg vulvar pruritu, genital moniliasis, vaginitis)
- Anaphylaxis
- pseudomembranous colitis
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Vitamin K antagonists (e.g. warfarin)
|
May enhance anticoagulant effect
|
|
Sodium picosulfate, BCG and typhoid vaccine
|
May diminish therapeutic effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
After reconstitution, Cefazolin is stable for 24 hours at room temperature or for 10 days if stored under refrigeration (5°C). Reconstituted solution may range in color from pale yellow to yellow without a change in potency.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.